News

Gladstone in the News October 18, 2020

Fetal Tissue Research, Donald Trump, and the Science behind the Politics

San Francisco Chronicle—Some of the treatments the president received for COVID-19 were developed using cells derived from human embryonic tissue. In addition, many of the COVID-19 vaccine candidates were developed using fetal cell lines. Gladstone Senior Investigator Warner Greene explains how valuable fetal tissue research has been to research on cancer, HIV, spinal cord injuries, and many other diseases. He also describes how the president’s 2019 decision to cut federal funding for fetal cell research has damaged that progress.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News October 18, 2020

Conservatives Confront Moral Dilemma of Vaccines and Treatments Derived from Fetal Tissue Cells

abc News—In 2019, the Trump administration suspended federal funding for research involving fetal tissue. Gladstone President Deepak Srivastava explains that if the funding ban had been in place over the last few decades, many important drugs—including treatments for COVID-19—would not have been developed.

Gladstone Experts COVID-19 Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs

Gladstone in the News October 17, 2020

Episode 10: Melanie Ott

Science is Fun!—Director of the Gladstone Institute of Virology Melanie Ott describes her latest work developing a CRISPR-based test for COVID-19, and the prospect for broadly acting antiviral therapeutics.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Article October 15, 2020

Gladstone Investigators Receive 4D Nucleome Award from the NIH

Benoit Bruneau and Katie Pollard study DNA folding to identify the genetic causes of congenital heart disease

Grants News Release Congenital Heart Disease Cardiovascular Disease Data Science and Biotechnology Bruneau Lab Pollard Lab

Article October 14, 2020

Young Scientists Committed to Finding Treatments for Neurodegenerative Diseases

The 2020 Berkelhammer Scholars break new ground in research on dementias, Parkinson’s disease, and neuropsychiatric disorders

Donor Stories Parkinson’s Disease Alzheimer’s Disease Dementia Neurological Disease Akassoglou Lab Kreitzer Lab Mahley Lab Mucke Lab Nakamura Lab

Gladstone in the News October 14, 2020

Trump’s COVID-19 Treatment Developed Using Cells Originally Drawn from Fetal Tissue

abc News—Gladstone President Deepak Srivastava, MD, comments on the fact that the experimental treatments President Trump received for COVID-19 were tested on cells that were derived from fetal tissue decades ago, and expresses concern that the Trump administration's current ban on the use of fetal tissue for research could slow efforts to curb the pandemic.

Gladstone Experts COVID-19 Cardiovascular Disease Srivastava Lab

Article October 13, 2020

Meet Gladstone: Leandro Lima

Learn how a Gladstone bioinformatician is spending his days during shelter-in-place

Profile Bioinformatics Core Finkbeiner Lab

Video October 12, 2020

Breakthrough Movie Discussion with Jim Allison

Jim Allison spoke along side a panel of experts in cancer immunotherapy.

Postdoctoral and Graduate Student Education and Research Development Affairs Postdoc Advisory Committee Graduate Students and Postdocs

Article October 12, 2020

The Women Who Have Inspired Gladstonians

Gladstone celebrates inspiring women in STEM

Womens Initiative Diversity

Gladstone in the News October 12, 2020

Refined Mapping of HIV’s Reservoir Could Aid in Cure Research

POZ—Finding a cure to HIV will require a full understanding of the latent reservoir, the population of cells in which the virus hides, evading antiretroviral therapy. Gladstone scientist Nadia Roan describes her recent work mapping an atlas of the reservoir, and how it provides hope that new therapies could be developed to target and eliminate reservoir cells.

Gladstone Experts HIV/AIDS Infectious Disease Roan Lab

Article October 12, 2020

Strong Women in STEM: A Conversation with Katie Pollard

In honor of Ada Lovelace Day, Katie Pollard discusses what it’s like to be a woman in STEM and how being an outsider has helped shape her career.

Mentoring Task Force Womens Initiative Profile Data Science and Biotechnology Pollard Lab Big Data Diversity

Article October 8, 2020

Having Hard Conversations about Race and STEM

A new series led by Gladstone, Georgia Tech, the Molecular Engineering & Sciences Institute at University of Washington, and UT Austin starts a national conversation about race and diversity in STEM fields.

Communications Elevated Voices Diversity

Gladstone in the News October 8, 2020

Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue

The New York Times—The experimental drugs used to treat President Trump for COVID-19 were developed with the help of a human cell line derived from a fetus aborted decades ago. Gladstone President Deepak Srivastava, MD, and Senior Investigator Warner Greene, MD, PhD, comment on the ethics of accepting this treatment while also banning research using newly derived fetal cells, in the process thwarting the development of life-saving treatments for other conditions.

Gladstone Experts COVID-19 Cardiovascular Disease Center for HIV Cure Research Greene Lab Srivastava Lab

Article October 7, 2020

Gladstone Investigator Jennifer Doudna Wins Nobel Prize in Chemistry

Doudna’s discovery of the CRISPR-Cas9 system revolutionized biomedical research

Awards News Release Data Science and Biotechnology Infectious Disease Doudna Lab CRISPR/Gene Editing

Article October 6, 2020

Gladstone Investigator Receives NIH Director’s New Innovator Award

Seth Shipman is recognized for his exceptionally creative research approach

Grants News Release Data Science and Biotechnology Shipman Lab